Patents by Inventor Guy ALLON

Guy ALLON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for aquaculturing
    Patent number: 12016353
    Abstract: A method of feeding an aquaculture of an aquatic animal species of interest is provided. The method comprising providing the aquaculture with an aquaculture feed comprising a sub-optimal dose of protein and an effective amount of butyric acid or salt thereof, the effective amount facilitating reducing feed conversion ratio (FCR). Also provided are feed compositions for aquaculturing.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: June 25, 2024
    Assignees: The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center), Israel Oceanographic and Limnological Research, Ltd. (PBC)
    Inventors: Amir Bitan, William Koven, Amos Tandler, Guy Allon
  • COMPOSITIONS AND METHODS FOR AQUACULTURING
    Publication number: 20210068426
    Abstract: A method of feeding an aquaculture of an aquatic animal species of interest is provided. The method comprising providing the aquaculture with an aquaculture feed comprising a sub-optimal dose of protein and an effective amount of butyric acid or salt thereof, the effective amount facilitating reducing feed conversion ratio (FCR). Also provided are feed compositions for aquaculturing.
    Type: Application
    Filed: November 8, 2018
    Publication date: March 11, 2021
    Applicants: The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization, Israel Oceanographic and Limnological Research, Ltd.
    Inventors: Amir BITAN, Willam KOVEN, Amos TANDLER, Guy ALLON
  • CHIMERIC ANTIGEN RECEPTOR FOR HER2/NEU AND T-CELLS EXPRESSING SAME
    Publication number: 20200215112
    Abstract: The present invention provides compositions and methods for improved T-cell therapy of cancer characterized by overexpression of Her2/neu oncogene. Provided are T cells capable of expressing or expressing chimeric antigen receptor (CAR) that specifically recognizes Her2/neu. These T cells have prolonged half-life in the blood circulation and enhanced cytotoxicity, and are used in treatment of a cancer characterized by overexpression of Her2/neu oncogene.
    Type: Application
    Filed: August 8, 2018
    Publication date: July 9, 2020
    Inventors: Debora Rosa BUBLIK, Zelig ESHHAR, Salomon STEMMER, Izhak HAVIV, Guy ALLON, Ido BACHELET, Yoav BEN YAACOV, Nadav COHEN